BCYC Bicycle Therapeutics plc
$3.86▲ +0.78%
Healthcare
Other
After hours
$3.86▲ +0.00%
Sep 11, 4:10 PM ET
Volume 621.2K
Avg Volume (10D) 416.0K
Key Metrics & Fundamentals
Market Cap
$270.17M
P/E Ratio
–
Div Yield
–%
52W Range
3.75 - 9.16
% vs 50 MA
-6.62%
% vs 200 MA
-24.91%
RSI-14
38.7
MACD Histogram
-0.0500
Beta (1Y vs SPY)
1.46
Free Cash Flow
-$49.87M
Gross Rev
$629,000
Gross Profit
$629,000
EBITDA
-$49.20M
COGS
–
Operating Exp
$55.26M
Operating Income
-$54.63M
EBIT
-$54.63M
Pretax Income
-$50.24M
Net Income
-$50.33M
EPS (Diluted)
-0.72
Price & Volume History
Loading chart…
Recent News
European Equities Traded in the US as American Depositary Receipts Decline in Wednesday Trading
MT Newswires · Sep 9, 2026 3:30 PM
European Equities Traded in the US as American Depositary Receipts Track Higher in Wednesday Trading
MT Newswires · Sep 2, 2026 3:13 PM
European Equities Traded in the US as American Depositary Receipts Edge Higher in Friday Trading
MT Newswires · Aug 28, 2026 3:22 PM
European Equities Traded in the US as American Depositary Receipts Track Higher in Friday Trading
MT Newswires · Aug 21, 2026 3:11 PM
European Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
MT Newswires · Aug 19, 2026 3:18 PM
European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading
MT Newswires · Aug 17, 2026 3:12 PM
European Equities Traded in the US as American Depositary Receipts Track Lower in Friday Trading
MT Newswires · Aug 14, 2026 3:08 PM
European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading
MT Newswires · Aug 7, 2026 3:14 PM
Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2026 Financial Results
Business Wire · Jul 30, 2026 11:00 AM
Tarsus Pharmaceuticals (TARS) Moves 7.5% Higher: Will This Strength Last?
Zacks · Jul 3, 2026 9:05 AM
Financial Overview - Income Statement
Quarterly
Jun 2026
See BCYC's money flow as a full page
Social Sentiment
Avg +0.80 · 1 posts
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.